Form 4 for NAGE Niagen Bioscience, Inc.
Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-07 · accession 0001628280-25-011466 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-10 | 2025-03-07 | NAGE | Lopez Carlos Luis | SVP, GC | P - Purchase | $7.86 | +273 | 2,251 | +14% | +$2,146 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | P | A | 273 | $7.86 | 2,251 | D | — | — |